Position in AXSM
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$505,939
+$31,500 QoQ
Shares Held
2,067
-26.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#325
of 503 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $2,906,060 across 6 Biotechnology names. AXSM ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
5,037 | $1,213,765 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,171 | $579,049 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
2,067 | $505,939 | |
| 4 | RPRX |
Royalty Pharma plc
|
5,951 | $333,672 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
511 | $253,829 | |
| 6 | GERN |
Geron Corp
|
15,474 | $19,806 |
All Filings in AXSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $505,939 | 2,067 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $474,439 | 2,807 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $729,829 | 3,996 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||